← Leaderboards
Alan Parr
Capture Pharmaceuticals, Inc
$3,742,227
Attributed
$3,742,227
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2015–22$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,742,227 · 2
By mechanism
R44$3,742,227 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelInvestigational New Drug ApplicationAnimalsClinical TrialsBaseInvestigational DrugsMedicalToxicologySafetyReportingPharmacologyPharmacologic SubstancePharmaceutical PreparationsNovel TherapeuticsFormulationDrug FormulationsAnestheticsAdolescentAnalytical MethodAddictionAcuteBlood CirculationAmerican Dental AssociationAcute Pain Management
Grant awards (4)
Non-opiate topical formulations for treating pain associated with molar extractions$715,640
R44 · FY2022 · DE · contact PI
Non-opiate topical formulations for treating pain associated with molar extractions$1,542,183
R44 · FY2021 · DE · contact PI
C2E2-An Orally Administered Radionuclide Decorporation Agent$741,636
R44 · FY2016 · AI · contact PI
C2E2-An Orally Administered Radionuclide Decorporation Agent$742,768
R44 · FY2015 · AI · contact PI